Researchers have discovered that a common plant in Brazil contains the cannabis ingredient cannabidiol (CBD). This discovery creates new opportunities for the production of the well-known substance from alternative sources.
A group of scientists from the Federal University of Rio de Janeiro uncovered CBD in the flowers and fruits of the Tremamicranthablume (trema) plant, a common shrub found throughout Brazil. According to lead scientist Rodrigo Moura Neto, the plant, which is sometimes categorized as a weed, is a promising source of CBD.
CBD, recognized for its potential in managing anxiety, chronic pain and epilepsy, stands as a key active component in marijuana, alongside tetrahydrocannabinol (THC), which is responsible for inducing the “high” associated with cannabis use.
While CBD’s medicinal efficacy remains under scientific scrutiny, Neto’s chemical analysis confirmed the presence of CBD in trema while ruling out the existence of THC. This development points to the likelihood of discovering additional sources of CBD, evading the legal constraints tethered to marijuana, which remains prohibited in many regions, including Brazil.
“It presents a legal alternative to marijuana use,” said Neto, highlighting the ubiquitous growth of trema throughout Brazil and emphasizing its potential as a more accessible and cost-effective CBD source. He also noted that CBD had previously been found in a related plant in Thailand.
Additionally, a different study published in May 2023 in the “Nature Plants” Journal revealed that the woolly umbrella, a plant native to South Africa, contained more than a dozen different types of cannabinoids. Despite the plant’s inability to produce CBD or THC, researchers did discover notable concentrations of cannabigerolic acid (CBGA), cannabichromene (CBC) and cannabibigerol (CBG).
Although Neto has not yet formally published his findings, he stated that he intends to broaden the study’s emphasis to include improving trema CBD extraction techniques and evaluating the drug’s efficacy in treating patients for ailments that are currently being treated with medicinal cannabis.
The Brazilian government recently awarded his team a grant of 500,000 real ($104,000) to continue the research, which he predicts will take at least five years to finish.
According to a survey conducted last year by market research company Vantage Market Research, the global market for CBD is currently expected to be worth close to $5 billion. The study also predicted that the industry will likely expand to exceed $47 billion by 2028, primarily due to the substance’s increasing popularity in health and wellness.
These research findings could open up new opportunities for the wider cannabis industry, including established actors such as SNDL Inc. (NASDAQ: SNDL), which could explore diversifying their operations.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
CannabisNewsWire is powered by IBN